dopamine system

The dopamine system is the network of neurons, pathways, and chemical machinery that produces, delivers, uses, and recycles dopamine throughout the brain. It’s one of the most-discussed systems in ADHD, and with good reason — differences in how this system works are closely linked to difficulties with motivation, attention, reward, and the ability to sustain effort on tasks that aren’t immediately interesting.

7 steps of dopamine production & delivery

Three main dopamine pathways run through the brain, each serving a different function.

• The mesolimbic pathway connects the ventral tegmental area to the nucleus accumbens and is involved in reward, motivation, and the ability to delay gratification.
• The mesocortical pathway connects the same region to the prefrontal cortex and supports executive function, working memory, and attention.
• The nigrostriatal pathway runs from the substantia nigra to the dorsal striatum and is involved in movement and action selection.

The same chemical is doing different jobs, depending on where the pathway runs in the brain.

Dopamine doesn’t just appear in the synapse (the gap between two neurons as they pass on information) and do its job. It’s manufactured, stored, released, received, collected, and broken down. This sequence of stages has its own requirements, and each station has its own potential bottleneck.

Dopamine production and delivery involve multiple stages, and a difference at any one stage produces different effects and responds to different interventions. It is useful to have a basic knowledge of this, because if you understand where in the system the difference lies in your brain, you can make more practical and informed decisions based on science.

1. Raw materials

Dopamine is built from tyrosine, an amino acid that comes from protein in food. Most people eating adequate protein have enough tyrosine available. This is rarely the bottleneck, which is why tyrosine supplements tend not to produce dramatic effects for most people — they’re adding more of something that usually isn’t in short supply.

2. Manufacturing

Tyrosine is converted into L-DOPA by the enzyme tyrosine hydroxylase. This is the rate-limiting step in the entire chain — everything downstream depends on this conversion happening fast enough, and this can cause a bottleneck.

Tyrosine hydroxylase requires iron as a cofactor to function. Without enough iron, the enzyme is present but can’t work at full capacity, and dopamine production slows. This is the step that connects the iron-dopamine research covered in our brain entry to the lived experience of attention and motivation difficulties.

3. Storage

Once dopamine is manufactured, it’s packaged into small containers called vesicles inside the neuron. The dopamine sits in these vesicles, ready to be released. This stage is less commonly discussed, but it has an important role: the neuron needs to have enough packaged dopamine available to respond when a signal arrives, so it can pass its own dopamine to its own neighbour and forward the message.

4. Release

When the neuron fires, the vesicles move to the cell membrane and release their dopamine into the synaptic gap — the space between the sending neuron and the receiving one. How much dopamine is released per firing event, and how reliably the release happens, varies between individuals and between different dopamine pathways.

5. Reception

The released dopamine binds to receptors on the receiving neuron. There are several receptor types (the D1 and D2 families are the most studied), and they don’t all do the same thing — some are excitatory, some are inhibitory. How many receptors are present and how sensitive they are determine how strongly the receiving neuron responds to the dopamine in the gap.

PET imaging in adults with ADHD has found reduced D2/D3 receptor availability in the nucleus accumbens and midbrain,¹ and these reductions correlated directly with symptoms of inattention — the lower the receptor availability, the more severe the attention difficulties.¹

6. Reuptake

After dopamine has been released and has bound to receptors, it doesn’t stay in the synapse indefinitely. Dopamine transporters (DAT) — proteins on the surface of the sending neuron — actively pull the dopamine back out of the gap and return it to the neuron for repackaging.

This stage is called reuptake, and this is the point in the chain where stimulant medications do their thing.

Methylphenidate (Ritalin, Concerta) blocks DAT, slowing the reuptake process so that dopamine remains in the synapse longer and has more time to activate receptors.

Lisdexamfetamine (Vyvanse, Elvanse) goes further: it increases dopamine release (stage 4), blocks reuptake (this stage), and inhibits breakdown (stage 7) simultaneously, which is why its effects are broader and why it can help people for whom methylphenidate alone isn’t enough.

Research using PET imaging has shown that the degree of dopamine increase in the ventral striatum after methylphenidate predicted how much inattention symptoms improved over 12 months of treatment.³ The medication works through the reward and motivation pathway, not just through attention circuits.

7. Breakdown

Dopamine that isn’t recaptured by transporters is broken down by enzymes in the synaptic gap — primarily MAO (monoamine oxidase) and COMT (catechol-O-methyltransferase). Genetic variants in the COMT gene affect how quickly this breakdown happens, which is one of the reasons the same dose of medication can feel different for different people. Some people clear dopamine from the synapse faster than others, and this is partly genetic.

Do ADHD brains have enough dopamine?

The popular version of dopamine is “ADHD means not enough dopamine.” The research tells a more precise story.⁴

Imaging studies in never-medicated adults with ADHD show reduced dopamine transporters and D2/D3 receptors in the nucleus accumbens and midbrain — the reward and motivation pathway.¹ Lower dopamine markers in the accumbens correlated with lower trait motivation on personality measures,² and lower motivation scores in turn predicted more severe inattention symptoms.² This is the biological basis for why the attentional difficulties in ADHD are worst during boring, repetitive, unrewarding tasks — the reward pathway isn’t supplying the motivational signal needed to sustain attention when the task itself doesn’t provide it.

But this isn’t a uniform deficit across the whole brain. Recent reviews conclude that ADHD likely involves region-specific and development-dependent dopamine differences — some circuits may be underactive while others compensate or overcompensate.⁴⁵ The mesocortical pathway (to the prefrontal cortex) shows different patterns from the mesolimbic pathway (to the accumbens), and the nigrostriatal pathway (movement circuits) has its own distinct profile.⁶⁷

A person’s specific combination of which pathways are most affected, and at which stage of the chain, shapes their individual ADHD presentation — which is part of why two people with the same diagnosis can have such different experiences.

Can supplements help with the dopamine system?

Understanding the seven stages is the framework that explains why different interventions work for different people.

If the bottleneck is at the raw material or manufacturing stage (1, 2)— not enough tyrosine, or not enough iron for the enzyme to work — then nutritional optimisation and addressing deficiencies can make a measurable difference. If the bottleneck is at reception (5) — fewer receptors, lower sensitivity — then increasing the amount of dopamine in the gap through medication becomes more important, because the system needs more signal to produce the same response. If the bottleneck is at reuptake (6)— dopamine being cleared too quickly — then a medication that slows that clearance is targeting the actual problem.

Supplements and medications act at different stages. Presenting them as interchangeable alternatives for everyone is a category error that simplifies a complex system and ignores people’s lived experience. For some people, nutritional support at stage 1 or 2 makes a real difference. For others, the bottleneck is at stage 5 or 6, and no amount of raw material will address it.